Insider Stock Trading History of Baker Charles A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Baker Charles A since year 2005. The trader's CIK number is 1225470. At the time of this reporting, Baker Charles A is the Director of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .

Note that in the past BAKER CHARLES A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Baker Charles A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-29 REGN Regeneron Pharmaceuticals Inc Option Ex 2,000 18.61 37,220
2017-09-29 REGN Regeneron Pharmaceuticals Inc Sale 2,000 450.00 900,000
2016-12-12 REGN Regeneron Pharmaceuticals Inc Option Ex 3,000 18.61 55,830
2016-12-12 REGN Regeneron Pharmaceuticals Inc Sale 3,000 392.48 1,177,446
2015-09-17 REGN Regeneron Pharmaceuticals Inc Option Ex 5,000 18.61 93,050
2015-09-17 REGN Regeneron Pharmaceuticals Inc Sale 5,000 550.00 2,750,000
2015-03-25 REGN Regeneron Pharmaceuticals Inc Option Ex 5,000 18.61 93,050
2015-03-25 REGN Regeneron Pharmaceuticals Inc Sale 5,000 454.93 2,274,660
2014-03-24 REGN Regeneron Pharmaceuticals Inc Sale 15,000 306.77 4,601,595
2014-03-24 REGN Regeneron Pharmaceuticals Inc Option Ex 15,000 23.84 357,600
2013-09-30 REGN Regeneron Pharmaceuticals Inc Option Ex 15,000 19.69 295,350
2013-09-30 REGN Regeneron Pharmaceuticals Inc Sale 15,000 313.33 4,699,920
2013-06-10 REGN Regeneron Pharmaceuticals Inc Sale 15,000 253.54 3,803,145
2013-06-10 REGN Regeneron Pharmaceuticals Inc Option Ex 15,000 15.80 237,000
2012-11-26 REGN Regeneron Pharmaceuticals Inc Option Ex 15,000 9.17 137,550
2012-11-26 REGN Regeneron Pharmaceuticals Inc Sale 15,000 173.47 2,601,990
2012-09-06 REGN Regeneron Pharmaceuticals Inc Sale 13,714 150.00 2,057,100
2012-09-05 REGN Regeneron Pharmaceuticals Inc Option Ex 1,286 15.01 19,302
2012-09-06 REGN Regeneron Pharmaceuticals Inc Option Ex 13,714 15.01 205,847
2012-09-05 REGN Regeneron Pharmaceuticals Inc Sale 1,286 150.00 192,900
2012-04-17 REGN Regeneron Pharmaceuticals Inc Option Ex 2,090 18.80 39,292
2012-04-17 REGN Regeneron Pharmaceuticals Inc Sale 2,090 125.00 261,250
2012-04-19 REGN Regeneron Pharmaceuticals Inc Option Ex 12,910 18.80 242,708
2012-04-19 REGN Regeneron Pharmaceuticals Inc Sale 12,910 125.00 1,613,750
2011-08-10 REGN Regeneron Pharmaceuticals Inc Option Ex 4,000 28.81 115,240
2011-07-01 REGN Regeneron Pharmaceuticals Inc Option Ex 11,000 28.81 316,910
2011-07-01 REGN Regeneron Pharmaceuticals Inc Sale 11,000 56.63 622,963
2010-06-02 REGN Regeneron Pharmaceuticals Inc Option Ex 5,000 25.43 127,150
2009-02-20 REGN Regeneron Pharmaceuticals Inc Option Ex 10,000 7.66 76,600
2009-02-20 REGN Regeneron Pharmaceuticals Inc Sale 10,000 18.16 181,600
2008-02-15 REGN Regeneron Pharmaceuticals Inc Option Ex 10,000 7.91 79,070
2008-02-15 REGN Regeneron Pharmaceuticals Inc Sale 10,000 18.85 188,460
2007-01-29 PGNX Progenics Pharmaceuticals Inc Option Ex 2,500 19.50 48,750
2007-01-29 PGNX Progenics Pharmaceuticals Inc Sale 2,500 30.02 75,050
2006-02-01 REGN Regeneron Pharmaceuticals Inc Option Ex 10,000 12.00 120,000
2006-02-01 REGN Regeneron Pharmaceuticals Inc Sale 10,000 15.35 153,520

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Charles A (Director of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.